Stemness-hypoxia genes PPARGC1A, PFKFB3, and SLC2A5 are associated with prognosis and tumor immune microenvironment in hepatocellular carcinoma.

Transl Cancer Res · 2025 · PMC12335690 · PMID 40792144

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

Moreover, we identified suppressive immune signature and elevated expression levels of immune checkpoint genes in the high-risk group, which may be significant for immunotherapy.

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Stemness-hypoxia genes &lt;i&gt;PPARGC1A&lt;/i&gt;, &lt;i&gt;PFKFB3&lt;/i&gt;, and &lt;i&gt;SLC2A5&lt;/i&gt; are associated with prognosis and tumor immune microenvironment in hepatocellular carcinoma.

The sentences

Stemness-hypoxia genes <i>PPARGC1A</i>, <i>PFKFB3</i>, and <i>SLC2A5</i> are associated with prognosis and tumor immune microenvironment in hepatocellular carcinoma.